Does LENACAPAVIR Cause Product use issue? 49 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 49 reports of Product use issue have been filed in association with LENACAPAVIR (Sunlenca). This represents 9.8% of all adverse event reports for LENACAPAVIR.
49
Reports of Product use issue with LENACAPAVIR
9.8%
of all LENACAPAVIR reports
0
Deaths
2
Hospitalizations
How Dangerous Is Product use issue From LENACAPAVIR?
Of the 49 reports, 2 (4.1%) required hospitalization.
Is Product use issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LENACAPAVIR. However, 49 reports have been filed with the FAERS database.
What Other Side Effects Does LENACAPAVIR Cause?
Off label use (95)
Injection site pain (58)
Injection site nodule (53)
Labelled drug-drug interaction medication error (43)
Injection site discharge (41)
Product use in unapproved therapeutic environment (40)
Injection site mass (23)
Viral load increased (21)
Fatigue (20)
Death (18)
What Other Drugs Cause Product use issue?
INFLIXIMAB (12,752)
DUPILUMAB (10,575)
POLYETHYLENE GLYCOL 3350 (9,432)
METHOTREXATE (8,185)
DICLOFENAC (8,009)
RITUXIMAB (6,948)
ADALIMUMAB (6,379)
ETANERCEPT (6,062)
TOCILIZUMAB (5,944)
ABATACEPT (5,915)
Which LENACAPAVIR Alternatives Have Lower Product use issue Risk?
LENACAPAVIR vs LENALIDOMIDE
LENACAPAVIR vs LENIOLISIB
LENACAPAVIR vs LENOGRASTIM
LENACAPAVIR vs LENVATINIB
LENACAPAVIR vs LEPONEX